Lipidomic Equipment Market Analysis/Forecast 2022-2028: Fully Automated Lipidomics Equipment Gaining Momentum & Opportunities in Escalating Government & Market Players Investment in Emerging Countries - ResearchAndMarkets.com
Retrieved on:
Monday, January 9, 2023
Biotechnology, Pharmaceutical, Health, Aurora, Science, Blood, Agilent Technologies, LIS, Central Food Technological Research Institute, Lipidomics, Mass spectrometry, Type 2 diabetes, Experiment, COVID-19, MS, CSIR, Lung cancer, DST, Research Foundation for Governance in India, Amity University, Administration for the Development of Weapons and Technological Infrastructure, Government, Risk, Degenerative disease, SCIEX, Research, Peking University Health Science Center, Thermo Fisher Scientific, Protein, Diagnosis, Growth, Department of Science and Technology (Philippines), Automation, Software, Artificial intelligence, LCMS, Lipid metabolism, Phosphorus, Lund University, Investment, Medical imaging, Fine chemical, Medical device, Lipid
Lipidomics involves system-level quantitation and identification of several networks and pathways of cellular lipids and interaction with other proteins and moieties.
Key Points:
- Lipidomics involves system-level quantitation and identification of several networks and pathways of cellular lipids and interaction with other proteins and moieties.
- Based on type, the lipidomic equipment market is segmented into targeted and untargeted.
- By offerings, the lipidomic equipment market is segmented into MS-based lipidomic technique, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software and services.
- Thus, automated lipidomic equipment is likely to emerge as a new trend in the lipidomic equipment market during the forecast period.